- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06098144
Smoking Cessation Program in the Construction Sector
Expanding the Role of the Safety Manager to Implement a Workplace Smoking Cessation Program in the Construction Sector
Study Overview
Status
Study Type
Enrollment (Estimated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Taghrid Asfar, MD
- Phone Number: 305-243-3826
- Email: tasfar@miami.edu
Study Contact Backup
- Name: Roxana De Dios Despaux, MPH
- Phone Number: 786-317-7927
- Email: rad317@miami.edu
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33136
- Recruiting
- Don Soffer Clinical Research Center
-
Principal Investigator:
- Taghrid Asfar, MD
-
Contact:
- Roxana De Dios Despaux, MPH
- Phone Number: 786-317-7927
- Email: rad317@miami.edu
-
Contact:
- Daniela Avendano, MS
- Phone Number: 305-915-0061
- Email: dxa1356@miami.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Company leaders:
- ≥ 18 years
- Involved in decision making
- Willing to participate in the implementation development and evaluation
Safety Managers:
- ≥ 18 years Self-identified as a safety manager or superintendent Have no plans to leave the company in the next year Speak either English or Spanish Non-cigarette smoker Willing to receive training in smoking cessation treatment Willing to deliver the smoking cessation treatment to workers
Construction Workers:
- Be a construction worker
- ≥ 18 years
- Have smoked on average 5 or more cigarettes daily for the past year
- Willing to make a serious quit attempt in the next 30 days
- Willing to receive treatment from the Florida Tobacco Quitline.
- Planning to stay in the company for the next 6 months
- Own a telephone and plan to keep it active for the next 12 months
Exclusion Criteria:
Safety Managers:
- Current cigarette smoker
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Phase 1 Group A: Tobacco Quit-line (TQL) Group
Participants will be referred to the TQL and will be followed up for up to 12 months.
|
The TQL is free, and the TQL counselor will provide three phone counseling sessions lasting approximately 15 minutes to devise a specific plan to quit smoking and arrange the delivery of 4 to 12 weeks of NRT based on need.
Participants will be advised to request nicotine gums instead of patches to accommodate their job circumstances.
|
|
Experimental: Phase 1 Group B: Brief Behavioral Counseling Group
Participants will receive one brief behavioral counseling session and two phone call follow-ups, then be followed up for 12 months. Besides the counseling session, they will be provided with Nicotine Replacement Therapy (NRT) and a referral to the TQL. For the NRT, participants will receive one box of Nicorette nicotine gums, 2 mg or 4 mg (depending on the number of cigarettes smoked), as well as 8 additional gums for a total of 168 gums during the counseling session. This amount is enough for 3 weeks. An additional 3-week supply will be provided at the second follow-up. |
The TQL is free, and the TQL counselor will provide three phone counseling sessions lasting approximately 15 minutes to devise a specific plan to quit smoking and arrange the delivery of 4 to 12 weeks of NRT based on need.
Participants will be advised to request nicotine gums instead of patches to accommodate their job circumstances.
The counseling session will discuss preparing to quit, coping with job-related stress, getting social support, the "5A's" for preventing relapse (Avoid, Alter, Alternatives, Anticipate, and Active), proper use of NRT, and last approximately 30 minutes.
Participants will receive a 6-week supply of nicotine replacement treatment (NRT). Based on participants' self-report on the number of cigarettes smoked, these are the possible dosages of NRT gum (2 mg and 4 mg). Participants should not smoke and use the nicotine gum at the same time. Nicotine gum should only be used when cravings for cigarettes arise and should not be treated like regular chewing gum. It is not to be constantly chewed NRT will be distributed based on the treatment condition. |
|
Experimental: Phase 2 Group A: Second Tobacco Quit-line (TQL) Group
Participants from Group A who did not quit smoking at the 3-month follow-up may receive a second referral to the TQL and will be followed up for up to 12 months.
|
The TQL is free, and the TQL counselor will provide three phone counseling sessions lasting approximately 15 minutes to devise a specific plan to quit smoking and arrange the delivery of 4 to 12 weeks of NRT based on need.
Participants will be advised to request nicotine gums instead of patches to accommodate their job circumstances.
|
|
Experimental: Phase 2 Group B: Second Brief Behavioral Counseling Group
Participants from Group B who did not quit smoking at the 3-month follow-up may receive a second brief behavioral counseling session and two phone call follow-ups, then be followed up for 12 months. Besides the counseling session, they will be provided with Nicotine Replacement Therapy (NRT) and a second referral to the TQL. For the NRT, participants will receive one box of Nicorette nicotine gums, 2 mg or 4 mg (depending on the number of cigarettes smoked), as well as 8 additional gums for a total of 168 gums during the counseling session. This amount is enough for 3 weeks. An additional 3-week supply is provided at the second follow-up. |
The TQL is free, and the TQL counselor will provide three phone counseling sessions lasting approximately 15 minutes to devise a specific plan to quit smoking and arrange the delivery of 4 to 12 weeks of NRT based on need.
Participants will be advised to request nicotine gums instead of patches to accommodate their job circumstances.
The counseling session will discuss preparing to quit, coping with job-related stress, getting social support, the "5A's" for preventing relapse (Avoid, Alter, Alternatives, Anticipate, and Active), proper use of NRT, and last approximately 30 minutes.
Participants will receive a 6-week supply of nicotine replacement treatment (NRT). Based on participants' self-report on the number of cigarettes smoked, these are the possible dosages of NRT gum (2 mg and 4 mg). Participants should not smoke and use the nicotine gum at the same time. Nicotine gum should only be used when cravings for cigarettes arise and should not be treated like regular chewing gum. It is not to be constantly chewed NRT will be distributed based on the treatment condition. |
|
Experimental: Phase 2 Group A + C: TQL and Intensive Behavioral Counseling Group
Participants from Phase 1 Group A who did not quit smoking at the 3-month follow-up may receive four behavioral counseling sessions, two phone-call follow-ups, and Nicotine Replacement Therapy (NRT) and be followed up for 12 months. For the NRT, participants will receive one box of Nicorette nicotine gums, 2 mg or 4 mg (depending on the number of cigarettes smoked), as well as 8 additional gums for a total of 168 gums during the first counseling session. This amount is enough for 3 weeks. An additional 3-week supply is provided at the fourth session. |
The TQL is free, and the TQL counselor will provide three phone counseling sessions lasting approximately 15 minutes to devise a specific plan to quit smoking and arrange the delivery of 4 to 12 weeks of NRT based on need.
Participants will be advised to request nicotine gums instead of patches to accommodate their job circumstances.
Participants will receive four weekly counseling sessions which include information about how to quit, challenges, and short and long-term relapse prevention.
Each session will last approximately 20 minutes.
Participants will receive a 6-week supply of nicotine replacement treatment (NRT). Based on participants' self-report on the number of cigarettes smoked, these are the possible dosages of NRT gum (2 mg and 4 mg). Participants should not smoke and use the nicotine gum at the same time. Nicotine gum should only be used when cravings for cigarettes arise and should not be treated like regular chewing gum. It is not to be constantly chewed NRT will be distributed based on the treatment condition. |
|
Experimental: Phase 2 Group B + C: Brief Counseling and Intensive Behavioral Counseling Group
Participants from Phase 1 Group B who did not quit smoking at the 3-month follow-up may receive four behavioral counseling sessions, two phone-call follow-ups, and Nicotine Replacement Therapy (NRT) and be followed up for 12 months. For the NRT, participants will receive one box of Nicorette nicotine gums, 2 mg or 4 mg (depending on the number of cigarettes smoked), as well as 8 additional gums for a total of 168 gums during the first counseling session. This amount is enough for 3 weeks. An additional 3-week supply is provided at the fourth session. |
The TQL is free, and the TQL counselor will provide three phone counseling sessions lasting approximately 15 minutes to devise a specific plan to quit smoking and arrange the delivery of 4 to 12 weeks of NRT based on need.
Participants will be advised to request nicotine gums instead of patches to accommodate their job circumstances.
The counseling session will discuss preparing to quit, coping with job-related stress, getting social support, the "5A's" for preventing relapse (Avoid, Alter, Alternatives, Anticipate, and Active), proper use of NRT, and last approximately 30 minutes.
Participants will receive four weekly counseling sessions which include information about how to quit, challenges, and short and long-term relapse prevention.
Each session will last approximately 20 minutes.
Participants will receive a 6-week supply of nicotine replacement treatment (NRT). Based on participants' self-report on the number of cigarettes smoked, these are the possible dosages of NRT gum (2 mg and 4 mg). Participants should not smoke and use the nicotine gum at the same time. Nicotine gum should only be used when cravings for cigarettes arise and should not be treated like regular chewing gum. It is not to be constantly chewed NRT will be distributed based on the treatment condition. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Program Effectiveness Measure in Percentage
Time Frame: Up to 4 years
|
Will be collected as the difference in percentage of participants who quit smoking at the 12-month follow-up assessment between the three treatment groups.
|
Up to 4 years
|
|
Program Cost-Effectiveness Measured by Number of U.S Dollars
Time Frame: Up to 4 years
|
Will be measured as the difference in the number of U.S. dollars between the three programs.
|
Up to 4 years
|
|
Program Cost-Effectiveness Measured by Quality Adjusted Life Years
Time Frame: Up to 4 years
|
Will be measured by quality-adjusted life years defined as the difference in the number of years lived in perfect health between the three programs.
|
Up to 4 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Program's Implementation- Acceptability Measured by Likert Scale
Time Frame: Up to 4 years
|
Using the Acceptability of Intervention Measure, acceptability will be scored on a 5-point Likert scale, with higher scores indicating greater acceptability.
|
Up to 4 years
|
|
Program's Implementation- Feasibility Measured by Likert Scale
Time Frame: Up to 4 years
|
Using the Feasibility of Intervention Measure, feasibility will be scored on a 5-point Likert scale, with higher scores indicating greater feasibility.
|
Up to 4 years
|
|
Program's Implementation- Sustainability Measured by Likert Scale
Time Frame: Up to 4 years
|
Using the Intervention Sustainability Assessment Tool, sustainability will be scored on a 7-point Likert scale, with higher scores indicating greater sustainability.
|
Up to 4 years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Taghrid Asfar, MD, tasfar@miami.edu
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Behavior
- Smoking
- Health Behavior
- Tobacco Use
- Smoking Cessation
- Tobacco Smoking
- Tobacco Use Cessation
- Therapeutics
- Food
- Diet, Food, and Nutrition
- Physiological Phenomena
- Food and Beverages
- Carbohydrates
- Polymers
- Macromolecular Substances
- Polysaccharides
- Biopolymers
- Plant Gums
- Candy
- Chewing Gum
- Tobacco Use Cessation Devices
- Nicotine Chewing Gum
Other Study ID Numbers
- 20230549
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
National University of SingaporeRecruitingSmoking &Amp; Tobacco CessationSingapore
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedSmoking &Amp; Tobacco CessationUnited States
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Sultan Qaboos UniversityCompletedSmoking Cessation | Tobacco Use Cessation | Smoking PreventionOman
-
University of VermontMayo Clinic; Alaska Native Tribal Health ConsortiumTerminatedSmoking | Smoking CessationUnited States
Clinical Trials on Tobacco Quit-line
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI)Completed
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); National Institutes of Health (NIH)Enrolling by invitationSmoking | Smoking Cessation | Tobacco UseUnited States
-
Ohio State UniversityNational Cancer Institute (NCI)CompletedTobacco Dependence
-
University of Wisconsin, MadisonNational Institute on Drug Abuse (NIDA)CompletedNicotine DependenceUnited States
-
Southern Illinois UniversityAmerican Lung AssociationCompleted
-
Duke UniversityNational Institute on Drug Abuse (NIDA); Consumer Wellness SolutionsCompleted
-
University of Wisconsin, MadisonCompleted
-
University of FloridaPatient-Centered Outcomes Research InstituteRecruitingTobacco Use CessationUnited States
-
University of MichiganBlue Cross Blue Shield of Michigan FoundationCompletedSmoking | Tobacco Use CessationUnited States
-
Johns Hopkins UniversityCompletedSmoking Cessation | Hypertension